Boyden, a premier global talent and leadership advisory firm with more than 65 offices in over 40 countries, released its latest issue of the Boyden Leadership Series, featuring an in-depth interview with Theo van der Loo, President of Bayer Brazil.
In the interview, van der Loo shares insights on the importance of staying focused to achieve the best financial results, as well as the key characteristics he believes keep a workforce innovative, socially aware, and most importantly, ahead of the competition.
“Theo’s ability to motivate and drive innovation has created a dynamic Bayer culture that is highly focused on delivering the best results for its customers, investors and employees”, said Trina Gordon, President & CEO of Boyden. “His deep knowledge of the Brazilian market, combined with his extensive global experience, make him uniquely placed to offer insights on the changing dynamics and human capital trends in the pharmaceutical and life sciences sectors.”
“As a widely recognized industry figure, an important part of Theo’s impressive career has been his ability to build talent and manage great teams”, said Aurea Imai, a Managing Partner of Boyden Brazil and leading member of the firm’s Global Healthcare & Life Sciences Practice. “The insights he shares are applicable to all types of aspiring young managers as well as established executives looking to accelerate their careers.”
Van der Loo has been President and Country Speaker for Bayer in Brazil since 2011. He is a native Brazilian and has lived in Europe, where he earned his bachelor’s degree in business, followed by an MBA in the United States. He returned to Brazil in 1980, starting as a management trainee in the pharmaceutical industry, and later joining Schering AG in Brazil as Marketing Director, while working across Berlin, Mexico City and Madrid. When Bayer acquired Schering, van der Loo became responsible for the Bayer HealthCare Division, moving ultimately into his current role.
During his career, van der Loo has been elected Chairman of the Board of Interfarma (Brazilian Research-Based Pharmaceutical Manufacturers Association) four times. He is also currently a Board Director at Sindusfarma (Industry Syndicate of Pharmaceutical Products in the State of São Paulo) and the German Chamber of Commerce - São Paulo, and a member of the Advisory Board at ETCO.